# Ricardo Correa‐Rotter

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ricardo-correa-rotter/

## Facts

| Field | Value |
| --- | --- |
| Citations | 19,453 |
| Field | Chronic Kidney Disease and Diabetes |
| h-index | 53 |
| i10-index | 141 |
| Last Known Institution | Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán |
| OpenAlex ID | https://openalex.org/A5060560730 |
| ORCID iD | https://orcid.org/0000-0003-0100-8285 |
| Works | 311 |

## Researcher papers

- [Dapagliflozin in Patients with Chronic Kidney Disease](https://scholariq.org/papers/dapagliflozin-in-patients-with-chronic-kidney-disease/)
- [Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention](https://scholariq.org/papers/chronic-kidney-disease-and-cardiovascular-risk-epidemiology-mechanisms-and/)
- [Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy](https://scholariq.org/papers/global-kidney-health-2017-and-beyond-a-roadmap-for-closing-gaps-in-care-research/)
- [Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effects-of-dapagliflozin-on-major-adverse-kidney-and-cardiovascular-events-in/)
- [A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy](https://scholariq.org/papers/a-pre-specified-analysis-of-the-dapa-ckd-trial-demonstrates-the-effects-of/)
- [A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide \[Recombinant Human Parathyroid Hormone (1–34)\] with Alendronate in Postmenopausal Women with Osteoporosis](https://scholariq.org/papers/a-randomized-double-blind-trial-to-compare-the-efficacy-of-teriparatide/)
- [Fructokinase activity mediates dehydration-induced renal injury](https://scholariq.org/papers/fructokinase-activity-mediates-dehydration-induced-renal-injury/)
- [Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effect-of-dapagliflozin-on-urinary-albumin-excretion-in-patients-with-chronic/)
- [Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial](https://scholariq.org/papers/effect-of-dapagliflozin-on-the-rate-of-decline-in-kidney-function-in-patients/)
- [The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics](https://scholariq.org/papers/the-dapagliflozin-and-prevention-of-adverse-outcomes-in-chronic-kidney-disease/)

## Researcher topics

- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Organ Donation and Transplantation](https://scholariq.org/topics/organ-donation-and-transplantation/)
- [Blood Pressure and Hypertension Studies](https://scholariq.org/topics/blood-pressure-and-hypertension-studies/)

## Researcher university

- [Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán](https://scholariq.org/institutions/instituto-nacional-de-ciencias-medicas-y-nutricion-salvador-zubiran/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.